| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 04/23/2009 | CA2702898A1 Inhibitors of c-fms kinase |
| 04/23/2009 | CA2700161A1 Novel method for the synthesis of anticancer (poly)aminoalkylaminoacetamide derivatives of epipodophyllotoxin |
| 04/22/2009 | EP2049547A2 Aza-peptide protease inhibitors |
| 04/22/2009 | EP2049546A1 Dihydrofuro pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2003135A9 Process for producing optically active chromene oxide compound |
| 04/22/2009 | EP2002832A9 Composition containing lignan compound |
| 04/22/2009 | EP1395539B1 A method for isolating phenolic substances or juvabiones from wood comprising knotwood |
| 04/22/2009 | EP1387842B1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 04/22/2009 | CN101415714A Chiral diole compounds, liquid crystal compositions and polymer networks derived therefrom |
| 04/22/2009 | CN101412725A Method for extracting and separating bilobalide B from ginkgo leaf |
| 04/22/2009 | CN101412724A Method for extracting bilobalide compound from ginkgo leaf |
| 04/22/2009 | CN101412723A Method for extracting and separating bilobalide J from ginkgo leaf |
| 04/22/2009 | CN101412722A Method for extracting and separating bilobalide C from ginkgo leaf |
| 04/22/2009 | CN101412721A 6,13-substituted pentacene and derivatives thereof, as well as preparation |
| 04/22/2009 | CN101412651A Pentacenes and derivatives thereof, as well as thereof |
| 04/22/2009 | CN100480250C Bromodihydroartemisinin and preparation method thereof |
| 04/22/2009 | CN100480225C Method for producing c1-c15 fragments of epothilones and the derivatives thereof |
| 04/21/2009 | US7521571 Compounds such as 2-thioisosorbide 5-mononitrate or 5,5'-dinitrate-2,2'-dithiodiisosorbide or 2-methylthioisosorbide 5-mononitrate; cardiovascular diseases such as, atherosclerosis, cardiac allograft vasculopathy, and tissue damage due to ischemia and/or to ischemia-reperfusion |
| 04/21/2009 | US7521568 Enantiopure 4-deoxypentenosides, dihydropyrans and tetrahydropyrans and syntheses thereof |
| 04/21/2009 | US7521478 Antitumor agents; synthetic derivatives equivalent to marine polyketide derived components isolated from bryozoan Myriapora truncata; removing protecting groups from intermediates |
| 04/21/2009 | US7521474 For blocking cellular proliferation, treatment of cancer/fungal infections, controlling spoilage of food, and in cosmetics |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/16/2009 | WO2009049041A2 Polyketal compounds, synthesis, and applications |
| 04/16/2009 | WO2009046640A1 Myrothecium sp. mycelial extract for inhibiting tumor cells growth |
| 04/16/2009 | WO2008124571A3 Anti-viral compounds, compositions and methods |
| 04/16/2009 | WO2006044496A3 Identification and screening of triptolide target molecules |
| 04/16/2009 | US20090098086 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors |
| 04/16/2009 | CA2701626A1 Compounds from myrothecium sp. for inhibiting the growth of cancer cells |
| 04/15/2009 | EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 04/15/2009 | EP1432680B1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 04/15/2009 | CN101408728A Resist composition, method of forming resist pattern, novel compound and method of producing the same |
| 04/15/2009 | CN101407523A Myrothecium mycelium extract for inhibiting growth of tumour cell |
| 04/15/2009 | CN101407522A Preparation of amyrolin and derivatives thereof |
| 04/15/2009 | CN101407521A Preparation of 1-methyl-3,4-O-isopropyl-2-deoxy-beta-L-arabinose |
| 04/15/2009 | CN100478344C Use of compound metabolized by diaporthe phaseolorum fungus |
| 04/14/2009 | US7518002 High purity phthalein derivatives and method for preparing same |
| 04/14/2009 | US7517471 And benzo[1,2-b:3,4-b']difuran derivatives; liquid crystal media, electrooptical displays; negative Delta epsilon, vertically alligned thin film transistors |
| 04/14/2009 | CA2256007C Substituted heterocyclic benzocycloalkenes and their use as analgesic |
| 04/09/2009 | WO2009046308A1 Intermediates and methods for the synthesis of halichondrin b analogs |
| 04/09/2009 | WO2009043538A1 Artemisinin derivatives for the treatment of melanoma |
| 04/09/2009 | WO2005054429A3 Synthesis of the c1-c6 keto-acid synthon of the epothilones |
| 04/09/2009 | US20090093646 Novel compound of stemphones and production thereof |
| 04/09/2009 | US20090093641 Synthesis of Pentafluorosulfanyl (SF5)-Substituted Heterocycles and Alkynes |
| 04/09/2009 | US20090093459 2-alkoxy-3,4,5-trihydroxyalkylamide-benzothiazepines preparation thereof, compositions containing them and use thereof |
| 04/09/2009 | US20090093069 Topiramate Immunoassays |
| 04/09/2009 | CA2701534A1 Intermediates and methods for the synthesis of halichondrin b analogs |
| 04/08/2009 | EP2045242A1 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/08/2009 | EP2044081A2 Improved oxidation process with enhanced safety useful in the manufacture of moxidectin by means of stabilised 2-iodoxybenzoic acid (sibx) |
| 04/08/2009 | EP1461340B1 Trioxane derivatives as antimalaria or anticancer compounds |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | CN101405291A 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel |
| 04/08/2009 | CN101402661A Uses of iridoid glycoside compounds in preparing hemostatic and pain easing medicament |
| 04/08/2009 | CN101402554A 2- and 2,5-substituted phenylketo-enols |
| 04/08/2009 | CN100475820C Method for refining pyromellitic anhydride by solvent |
| 04/08/2009 | CN100475819C Pseudopolymorphic forms of a HIV protease inhibitor |
| 04/08/2009 | CN100475800C Processes for preparing bicyclo[3.1.0]hexane derivatives, and intermediates thereto |
| 04/07/2009 | US7514572 Spiro ortho ester-ether-substituted furocoumarins derived from citrus fruits, especially grapefruit; nontoxic |
| 04/07/2009 | CA2453382C Mannitol and glucitol derivatives |
| 04/07/2009 | CA2352505C Epothilone derivatives and their use as antitumor agents |
| 04/07/2009 | CA2312856C Use of ginkgo biloba extracts for preparing a medicine |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/02/2009 | WO2009041592A1 Oxidizing agent composition for epoxidation and oxidation method thereof |
| 04/02/2009 | WO2009040456A1 Novel chemotherapeutic agents for treating cancer |
| 04/02/2009 | WO2009040119A2 Process for manufacturing artemisinin |
| 04/01/2009 | EP1638960A4 Preparation of chemical compounds |
| 04/01/2009 | CN101400668A 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors |
| 04/01/2009 | CN101397303A Sanggenole A compounds, preparation method and use thereof |
| 04/01/2009 | CN100473651C Pyrazolyl-substituted heterocycles and use thereof as phytosanitary products |
| 04/01/2009 | CN100473381C Use of epothilones in the treatment of brain diseases associated with proliferative processes |
| 03/31/2009 | US7511159 Azetidine ring compounds and drugs comprising the same |
| 03/31/2009 | CA2366256C Tropane analogs and methods for inhibition of monoamine transport |
| 03/26/2009 | WO2009039407A1 Water-soluble and water-insoluble, ring opening metathesis polymerization products, monomers and related methods |
| 03/26/2009 | WO2009038673A2 Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
| 03/26/2009 | WO2009038089A1 Anti-fatigue agent comprising sesamin and vitamin-e |
| 03/26/2009 | WO2009037302A1 5-substituted-1, 4-benz0diazepines as phosphodiesterase inhibitors |
| 03/26/2009 | WO2008145921A3 Novel functional compounds with an isosorbide or isosorbide isomer core, production process and uses of these compounds |
| 03/26/2009 | US20090082524 Water-Soluble and Water-Insoluble, Ring Opening Metathesis Polymerization Products, Monomers and Related Methods |
| 03/26/2009 | US20090082428 Spiroketals |
| 03/26/2009 | US20090082393 New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1697379B1 Spirocyclic cyclohexane derivatives |
| 03/25/2009 | CN101392000A High efficiency separation purification method of ginkgolide A, B, C, J and bilobalide monomer |
| 03/25/2009 | CN101391973A Salts for adding angiotensin conversion enzyme inhibitors to no-donor acids, method of preparing same and pharmaceutical compositions containing them |
| 03/24/2009 | US7507764 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
| 03/24/2009 | US7507763 Enzyme inhibitor for treating HIV infections in mammals; viricides; patient is suffering from a multi-drug resistant HIV infection; Aids therapy |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507395 Include pH-sensitive fluorescent and fluorogenic 2',7'-dialkylfluorescein derivatives and associated nonfluorescent precursor compounds; malignancy, multidrug resistance, lysosome storage disease, corneal acidosis, ulcer disease, diabetic heart condition, or hyperglycemia |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2348579C Azadirachtin compounds extracted from azadirachta indica, compositions and use thereof as insecticidal |
| 03/19/2009 | WO2009036106A1 Cytotoxic xanthone compounds |
| 03/19/2009 | WO2009034790A1 Fluorescent molecule |
| 03/19/2009 | WO2009034329A1 Solvents |
| 03/19/2009 | WO2009033706A1 Increasing the in vivo biological activity of biologically active compounds |
| 03/19/2009 | WO2009033704A1 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones |
| 03/19/2009 | WO2009033494A1 1- or 2-substituted artemisinin derivatives for increasing the in vivo biological activity of biologically active compounds |
| 03/19/2009 | WO2009008980A3 Tetrahydropyranochromene gamma secretase inhibitors |
| 03/19/2009 | US20090076138 Deuterium-enriched darunavir |
| 03/19/2009 | US20090075971 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same |
| 03/19/2009 | US20090075970 Thieno-and furo-pyrimidine modulators of the histamine H4 receptor |
| 03/19/2009 | CA2698973A1 1- or 2-substituted artemisinin derivatives for increasing the in vivo biological activity of biologically active compounds |